Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

PharmaCyte Biotech (pmcb)

Total paid for Promotions this month: $0
E-mails this Month: 1
Estimated Volume Generated: $0
Research Report on pmcb: Click to see
* The information presented is based on information for Jun , 2016

Meet PMCB And Its NEWS Feb 03, 2015 09:36

  Pre-Clinical Stage Biotech For Barely $0.10   Greetings, Trader!   PharmaCyte Biotech Inc. (PMCB) may be a new ticker for you but the company is finally hinting that it’s tired of its technology getting ignored.   PMCB HAS WHAT MIGHT BE A CURE FOR DIABETES ON ITS BOOKS! AND AS OF YESTERDAY, IT’S MOVING TOWARD THE CLINIC! (Read more)   That little ...read more
Promoter: The Penny Stocks Finder Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $14,500 UNKNOWN
Max Profit: 13.08 % Gain at close: Pending
    FOR: Tuesday, January 27, 2015   OTC: PMCB         PharmaCyte Biotech, Inc. (PMCB)         Attention Traders!     As A Reminder Our New Pick For Tuesday Is:  PMCB     If you have been a member for a while now, you probably already know that some of our biggest gains ever have been biotech picks that have absolutely soared just ...read more
Promoter: Penny Pick Finders Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $15,000 UNKNOWN
Max Profit: 0.71 % Gain at close: Pending
PharmaCyte Biotech, Inc. (PMCB) PharmaCyte Biotech, Inc. (PMCB), formerly Nuvilex, Inc., is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. This technology will be used as a platform upon which treatments ...read more
Promoter: PST Alerts Paying Party: Galaxy LLC
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $5,000 UNKNOWN
Max Profit: 0.71 % Gain at close: Pending
PharmaCyte Biotech, Inc. (PMCB) PharmaCyte Biotech, Inc. (PMCB), formerly Nuvilex, Inc., is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. This technology will be used as a platform upon which treatments ...read more
Promoter: Buzz Stocks Paying Party: Galaxy LLC
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $5,000 UNKNOWN
Max Profit: 0.71 % Gain at close: Pending
  PSP Free Members   I am issuing a new biotech play for 2015!     If you have been a member for a while now, you probably already know thatsome of our biggest gains ever have been biotech picks that have absolutely soared just weeks after we made them official picks.   Our new pick could be ready for a huge move in 2015.    This biotech play has the exclusive ...read more
Promoter: Penny Stock Prophet Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $15,000 UNKNOWN
Max Profit: 0.71 % Gain at close: Pending
    FOR: Tuesday, January 27, 2015   OTC: PMCB         PharmaCyte Biotech, Inc. (PMCB)         Attention Traders!     We are issuing a major new biotech play for 2015!       If you have been a member for a while now, you probably already know that some of our biggest gains ever have been biotech picks that have absolutely soared ...read more
Promoter: Penny Pick Finders Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $15,000 UNKNOWN
Max Profit: 0.71 % Gain at close: Pending
  New Momentum Alert: PMCB   SSP Subscribers,   Our new pick could be ready for a huge move in 2015.   This biotech play has the exclusive rights to a technology that could redefine the way we treat pancreatic cancer.   Earlier this month, and for most of the past 6 months this pick was in the 20-cent range, but at only 13-14 cents right now could be an incredible Bottom Floor Opportunity. In fact, ...read more
Promoter: SecretStockPromo Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $15,000 UNKNOWN
Max Profit: 0.71 % Gain at close: Pending
New Breakout Alert: PMCB Secret Stock Members,         Our new pick could be ready for a huge move in 2015.  This biotech play has the exclusive rights to a technology that could redefine the way we treat pancreatic cancer.  Earlier this month, and for most of the past 6 months this pick was in the 20-cent range, but at only 13-14 cents ...read more
Promoter: SecretStockPromoter Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $15,000 UNKNOWN
Max Profit: 0.71 % Gain at close: Pending
   January 26, 2015 Volume XVIII, Issue 2   OTC Journal Newsletter   Nuvilex Evolves: Pharmacyte (PMCB) Strengthens Will people ever learn? We'll find out. I'm of course referencing the biotech company formerly known as Nuvilex (NVLX). In case you missed it, NVLX changed names to Pharmacyte (PMCB). On January 7th NVLX- the biotech stock I've been covering for many years changed ...read more
Promoter: OTCJournal Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $5,000 UNKNOWN
Max Profit: 1.05 % Gain at close: Pending
  Todays Pick is: PMCB Hello Everyone, We hope everybody has been enjoying their weekend! We sent out a huge report on PMCB this past Friday and hopefully you've done your research by now. If not, hurry and do so before the markets open back up tomorrow! Biotech stocks can sometimes be the most rewarding to investors. Finding a small-cap biotech stock with big board potential is not easy but we think we found one with PMCB!! We'll ...read more
Promoter: Penny Stocks Profile Paying Party: Penny Stock Egghead
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $2,000 UNKNOWN
Max Profit: 1.05 % Gain at close: Pending
First  << 12  13  14  15  16  17  18  >> Last